Avid Bioservices Inc (CDMO)

[biopharm]

David Carbone : Peregrine Pharmaceuticals KOL :

More Tools Than Ever Before for Treating Lung Cancer

8:35 Video Interview with David Carbone- Patient Power -

Published on Mar 31, 2015

Lung cancer continues to ride the wave of immunotherapy success, offering an array of new tools and drug combinations yet to be explored. Dr. David P. Carbone, director of the James Thoracic Center at James Cancer Hospital and Solove Research Institute stresses the proactive importance of designing unique, curative therapies versus reactive treatments. In Dr. Carbone's own words, "Everybody's lung cancer is different…the first treatment in your cancer is the most important." He explains how critical it is to "start with the right therapy, rather than just any therapy." Listen and learn why this is a pivotal time in the treatment of lung cancer as the treatment armamentarium continues to grow.

---------------------------------------------------

(The below site.. another video-- was posted last month and another great video of Peregrine Pharmaceuticals KOL = David Carbone)

Why Cancer Made Me a Better Thoracic Oncologist
(61 plays as of this posting...)

Thoracic oncologist, Dr. David P. Carbone, speaks candidly about his experience with cancer and how having cancer shifted his family dynamics drastically. Married with four children, Dr. Carbone self-diagnosed his large b-cell lymphoma and received a partial lobectomy. With the cure-rate between 30%-50% at the time, his optimism was at an all-time low. Dr. Carbone shares how revealing the news to his then wife resulted in her departure of the marriage, leaving him a single parent of four young children. Listen as Dr. Carbone explains why having cancer has given him a new appreciation for life along with newfound empathy and perspective for his patients.

https://vimeo.com/122121136